242 related articles for article (PubMed ID: 1378473)
1. An immunochemical analysis of the human nuclear phosphoprotein p53. New monoclonal antibodies and epitope mapping using recombinant p53.
Vojtĕsek B; Bártek J; Midgley CA; Lane DP
J Immunol Methods; 1992 Jul; 151(1-2):237-44. PubMed ID: 1378473
[TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical analysis of the p53 oncoprotein on paraffin sections using a series of novel monoclonal antibodies.
Bártek J; Bártková J; Lukás J; Stasková Z; Vojtĕsek B; Lane DP
J Pathol; 1993 Jan; 169(1):27-34. PubMed ID: 8433213
[TBL] [Abstract][Full Text] [Related]
3. A new set of monoclonal antibodies directed to proline-rich and central regions of p53.
Voeltzel T; Morel AP; Rostan MC; Ji J; Chiodino C; Ponchel F; Vigouroux J; Caron de Fromentel C; Soussi T; Ozturk M
Hybrid Hybridomics; 2004 Oct; 23(5):287-92. PubMed ID: 15672606
[TBL] [Abstract][Full Text] [Related]
4. Nucleotide sequence of the porcine p53 cDNA, and the detection of recombinant porcine p53 expressed in vitro with a variety of anti-p53 antibodies.
Burr PD; Argyle DJ; Reid SW; Nasir L
Oncogene; 1999 Sep; 18(35):5005-9. PubMed ID: 10490836
[TBL] [Abstract][Full Text] [Related]
5. Mutations in p53 produce a common conformational effect that can be detected with a panel of monoclonal antibodies directed toward the central part of the p53 protein.
Legros Y; Meyer A; Ory K; Soussi T
Oncogene; 1994 Dec; 9(12):3689-94. PubMed ID: 7526318
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody to a multiphosphorylated, conformational epitope at the carboxy-terminus of p53.
Otvos L; Hoffmann R; Xiang ZQ; O I; Deng H; Wysocka M; Pease AM; Rogers ME; Blaszczyk-Thurin M; Ertl HC
Biochim Biophys Acta; 1998 Sep; 1404(3):457-74. PubMed ID: 9739174
[TBL] [Abstract][Full Text] [Related]
7. Conformational changes in p53 analysed using new antibodies to the core DNA binding domain of the protein.
Vojtesek B; Dolezalova H; Lauerova L; Svitakova M; Havlis P; Kovarik J; Midgley CA; Lane DP
Oncogene; 1995 Jan; 10(2):389-93. PubMed ID: 7530828
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of epitopes on human p53 using phage-displayed peptide libraries: insights into antibody-peptide interactions.
Stephen CW; Helminen P; Lane DP
J Mol Biol; 1995 Apr; 248(1):58-78. PubMed ID: 7537340
[TBL] [Abstract][Full Text] [Related]
9. Differences in epitope accessibility of p53 monoclonal antibodies suggest at least three conformations or states of protein binding of p53 protein in human tumor cell lines.
Danks MK; Whipple DO; McPake CR; Lu D; Harris LC
Cell Death Differ; 1998 Aug; 5(8):678-86. PubMed ID: 10200523
[TBL] [Abstract][Full Text] [Related]
10. A monoclonal antibody against DNA binding helix of p53 protein.
Yolcu E; Sayan BS; Yağci T; Cetin-Atalay R; Soussi T; Yurdusev N; Ozturk M
Oncogene; 2001 Mar; 20(11):1398-401. PubMed ID: 11313883
[TBL] [Abstract][Full Text] [Related]
11. Precise characterisation of monoclonal antibodies to the C-terminal region of p53 protein using the PEPSCAN ELISA technique and a new non-radioactive gel shift assay.
Pospísilová S; Brázda V; Amrichová J; Kamermeierová R; Palecek E; Vojtesek B
J Immunol Methods; 2000 Apr; 237(1-2):51-64. PubMed ID: 10725451
[TBL] [Abstract][Full Text] [Related]
12. Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers.
Craig AL; Burch L; Vojtesek B; Mikutowska J; Thompson A; Hupp TR
Biochem J; 1999 Aug; 342 ( Pt 1)(Pt 1):133-41. PubMed ID: 10432310
[TBL] [Abstract][Full Text] [Related]
13. Epitope analysis of the human p53 tumour suppressor protein.
Dolezalová H; Vojtĕsek B; Kovarík J
Folia Biol (Praha); 1997; 43(1):49-51. PubMed ID: 9158951
[TBL] [Abstract][Full Text] [Related]
14. Comparison of anti-p53 antibodies in immunoblotting.
Turpeinen M; Serpi R; Rahkolin M; Vähäkangas K
Biochem Biophys Res Commun; 2002 May; 293(2):850-6. PubMed ID: 12054549
[TBL] [Abstract][Full Text] [Related]
15. Abnormalities of the p53 tumour suppressor gene in human pancreatic cancer.
Barton CM; Staddon SL; Hughes CM; Hall PA; O'Sullivan C; Klöppel G; Theis B; Russell RC; Neoptolemos J; Williamson RC
Br J Cancer; 1991 Dec; 64(6):1076-82. PubMed ID: 1764370
[TBL] [Abstract][Full Text] [Related]
16. p53 protein immunostaining in routinely processed paraffin-embedded sections.
Bruner JM; Connelly JH; Saya H
Mod Pathol; 1993 Mar; 6(2):189-94. PubMed ID: 8483890
[TBL] [Abstract][Full Text] [Related]
17. [Immunochemical evidence of a mutated p53 protein expressed in human colorectal adenocarcinoma].
Hammel PR; Beuvon FX; Salmon RJ; Remvikos Y
Gastroenterol Clin Biol; 1991; 15(6-7):529-35. PubMed ID: 1916131
[TBL] [Abstract][Full Text] [Related]
18. The 'wildtype' conformation of p53: epitope mapping using hybrid proteins.
Wang PL; Sait F; Winter G
Oncogene; 2001 Apr; 20(18):2318-24. PubMed ID: 11402327
[TBL] [Abstract][Full Text] [Related]
19. p53 immunolabeling in archival paraffin-embedded tissues: optimal protocol based on microwave heating for eight antibodies on lung carcinomas.
Tenaud C; Negoescu A; Labat-Moleur F; Legros Y; Soussi T; Brambilla E
Mod Pathol; 1994 Oct; 7(8):853-9. PubMed ID: 7530851
[TBL] [Abstract][Full Text] [Related]
20. p53 autoantibodies from patients with head and neck cancer recognise common epitopes on the polypeptide chain of p53.
Saleh J; Brunner C; Gölzer R; Nastainczyk W; Montenarh M
Cancer Lett; 2006 Feb; 233(1):48-56. PubMed ID: 15913883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
